• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. SOX 2as A Prognostic Marker in Malignant Epithelial Ovarian Tumors

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

SOX 2as A Prognostic Marker in Malignant Epithelial Ovarian Tumors

    Author

    • Menna Allah Ayman Mohammed, Yousria Mohamed MohamedEl-Gohary, EmanTaherNour El-Dien, Mona Mostafa Ahmed
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: Ovarian cancer (OC) is considered the most lethal cancer of the female
reproductive system and ranked as the seventh most frequent cancer diagnosed
worldwide and the eighth leading cause of cancer-related death among women
worldwide. The most common type of Ovarian cancer is that originate from the ovarian
surface epithelium "Epithelial ovarian cancer" (EOC) which accounts for over 90% of
all ovarian malignancies and is the most lethal gynecologic malignancy. Sex
determining region Y-box 2 (SRY)-box 2 (SOX2) is one of the main members of the
Sox family which consists of at least 20 members that are divided into 8 groups (from A
to H, based on their high mobility group (HMG) sequence identity in humans). SOX2
expression has been reported at both the RNA and protein levels for many tumors, data
available from The Cancer Genome Atlas indicates that SOX2 mRNA is elevated in
many cancers, relative to normal tissue. The level of SOX2 expression in a tumor
represents a prognostic factor to determine the clinical outcome for a cancer patient.
As SOX2 has a great role in cancer stemness so SOX2 expression in OC is an
interesting issue for studying.

Keywords

  • Epithelial ovarian cancer (EOC)
  • Sex-Determining Region Y-box2 (SOX2)
  • XML
  • PDF 575.62 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 184
    • PDF Download: 238
European Journal of Molecular & Clinical Medicine
Volume 8, Issue 4
July 2021
Page 151-173
Files
  • XML
  • PDF 575.62 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 184
  • PDF Download: 238

APA

Ahmed, M. A. A. M. Y. M. M. E. E. M. M. (2021). SOX 2as A Prognostic Marker in Malignant Epithelial Ovarian Tumors. European Journal of Molecular & Clinical Medicine, 8(4), 151-173.

MLA

Menna Allah Ayman Mohammed, Yousria Mohamed MohamedEl-Gohary, EmanTaherNour El-Dien, Mona Mostafa Ahmed. "SOX 2as A Prognostic Marker in Malignant Epithelial Ovarian Tumors". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 151-173.

HARVARD

Ahmed, M. A. A. M. Y. M. M. E. E. M. M. (2021). 'SOX 2as A Prognostic Marker in Malignant Epithelial Ovarian Tumors', European Journal of Molecular & Clinical Medicine, 8(4), pp. 151-173.

VANCOUVER

Ahmed, M. A. A. M. Y. M. M. E. E. M. M. SOX 2as A Prognostic Marker in Malignant Epithelial Ovarian Tumors. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 151-173.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus